바소프레서 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 성장률(CAGR) 6.9%로 49억 2,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 고혈압 유병률 증가, 고급 패혈증 관리 가이드라인 채택 확대, 중환자 치료 기술에 대한 투자 증가, 패혈증성 쇼크 유병률 증가, 개별화된 중환자 치료에 대한 수요 증가 등 여러 가지 요인에 기인합니다. 이 기간의 주요 동향으로는 약물 제제의 발전, 맞춤형 치료법 개발, 스마트 수액 펌프의 혁신, 원격의료와 바소프레서 치료의 통합, 생분해성 바소프레서 임플란트 기술 혁신 등이 있습니다.
심장 질환의 유병률 증가는 향후 몇 년 동안 바소프레서 시장의 성장을 촉진할 것으로 예상됩니다. 심장질환에는 관상동맥질환, 부정맥, 심부전, 선천성 심장질환 등 심장의 구조와 기능에 영향을 미치는 다양한 질환이 포함됩니다. 좌식 생활이 증가함에 따라 비만과 심혈관계 건강 상태의 악화가 보편화되면서 심장 관련 질환의 위험이 크게 증가하고 있습니다. 혈관수축제는 혈관을 수축시켜 혈압을 상승시키고, 중요한 장기로의 혈류를 촉진하며, 중요한 조건에서 심혈관계 기능을 지원함으로써 심장 질환의 치료를 돕습니다. 예를 들어, 2023년 12월 호주 정부 기관인 호주 보건 복지 연구소는 관상동맥성 심장 질환(CHD)으로 인한 의사 진단 사망자 수가 2021년 1만 4,100명에서 2022년 1만 4,900명으로 증가했다고 보고했습니다. 결과적으로 심장질환의 증가율이 심폐소생술 시장 성장에 기여하고 있습니다.
바소프레서 시장의 신흥국 기업들은 혈압을 더 잘 조절하고 환자의 예후를 개선하기 위해 정맥 내(IV) 혈관압박제와 같은 첨단 솔루션 개발에 주력하고 있습니다. 정맥 내 혈관압박기는 중증 저혈압이나 쇼크 상태에 있는 환자의 혈관을 수축시키고 혈압을 상승시켜 중요한 장기에 충분한 혈류를 보장하는 데 사용됩니다. 예를 들어, 독일에 본사를 둔 제약사 프레제니우스 카비 AG는 2023년 6월 바소프레신 주사액 USP를 미국 시장에 출시해 중환자 치료 제품 라인업을 확대했습니다. 이 약은 수액이나 카테콜아민 투여 후에도 저혈압이 지속되는 혈관확장성 쇼크 성인에게 특히 적응증을 가지고 있습니다. 이 약은 1mL당 20유닛을 함유한 1회용 바이알입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 바소프레서 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 바소프레서 시장 : 성장률 분석
- 세계의 바소프레서 시장 실적 : 규모와 성장, 2019-2024
- 세계의 바소프레서 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 바소프레서 전체 시장(TAM)
제6장 시장 세분화
- 세계의 바소프레서 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 카테콜아민
- 비카테콜아민
- 바소프레신
- 세계의 바소프레서 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 정맥내(IV)
- 골내
- 흡입
- 세계의 바소프레서 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 저혈압 관리
- 패혈증성 쇼크 치료
- 심장성 쇼크 서포트
- 수술 후 관리
- 기타 집중 치료 애플리케이션
- 세계의 바소프레서 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 외래 수술 센터
- 응급의료 서비스
- 재택 케어 설정
- 세계의 바소프레서 시장 카테콜아민 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 노르에피네프린
- 에피네프린
- 도파민
- 이소프로테레노르
- 세계의 바소프레서 시장, 비카테콜아민 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 페닐에프린
- 안지오텐신 II
- 세계의 바소프레서 시장 바소프레신 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 바소프레신(데스모프레신)
제7장 지역별·국가별 분석
- 세계의 바소프레서 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 바소프레서 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 바소프레서 시장 : 경쟁 구도
- 바소프레서 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Merck And Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
- Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- Bauch & Lomb Incorporated
- Dr. Reddy's Laboratories Limited
- Hikma Pharmaceuticals PLC
- Endo Inc.
- Amphastar Pharmaceuticals Inc.
- American Regent Incorporated
- Celon Laboratories Ltd.
- Athenex Inc.
- Sagent Pharmaceuticals Inc.
- Civica Rx
- Eton Pharmaceuticals Inc.
- Amomed Pharma GmbH
- Health Biotech Limited
- Samarth Life Sciences Pvt. Ltd
- Pace Biotech Limited
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 바소프레서 시장 2029 : 새로운 기회를 제공하는 국가
- 바소프레서 시장 2029 : 새로운 기회를 제공하는 부문
- 바소프레서 시장 2029 : 성장 전략
제36장 부록
ksm
A vasopressor is a drug that constricts blood vessels, raising blood pressure by enhancing vascular tone. It is primarily used in critical care to manage severe hypotension and ensure adequate blood flow to vital organs. By stabilizing circulation, vasopressors help prevent life-threatening complications in critically ill patients.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main types of vasopressors include catecholamines, non-catecholamines, and vasopressin. Catecholamines are hormones such as dopamine, norepinephrine, and epinephrine, produced by the adrenal glands and involved in the body's stress response. These drugs can be administered through various routes, such as intravenous (IV), intraosseous, and inhalational methods, for applications such as managing hypotension, treating septic shock, supporting cardiogenic shock, post-surgical management, and others. They are used in various settings, including hospitals, ambulatory surgical centers, emergency medical services, and home care.
The vasopressor market research report is one of a series of new reports from The Business Research Company that provides vasopressor market statistics, including vasopressor industry global market size, regional shares, competitors with a vasopressor market share, detailed vasopressor market segments, market trends and opportunities, and any further data you may need to thrive in the vasopressor industry. This vasopressor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The vasopressor market size has grown strongly in recent years. It will grow from$3.51 billion in 2024 to $3.76 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to several factors, including the increasing geriatric population, rising healthcare expenditure, expanding government initiatives, a growing number of hospitals, and the increasing prevalence of cardiovascular diseases.
The vasopressor market size is expected to see strong growth in the next few years. It will grow to$4.92 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth during the forecast period can be attributed to several factors, including the rising incidence of hypertension, greater adoption of advanced sepsis management guidelines, increasing investments in critical care technologies, the growing prevalence of septic shock, and a rising demand for personalized critical care. Key trends during this period include advancements in drug formulations, the development of tailored therapies, technological innovations in smart infusion pumps, the integration of telemedicine with vasopressor therapy, and innovations in biodegradable vasopressor implants.
The growing prevalence of heart diseases is anticipated to fuel the expansion of the vasopressor market in the coming years. Heart diseases encompass a range of conditions that affect the heart's structure and functionality, including coronary artery disease, arrhythmias, heart failure, and congenital heart defects. With the rise in sedentary lifestyles, obesity and poor cardiovascular health are becoming more common, substantially elevating the risk of heart-related conditions. Vasopressors aid in the treatment of heart disease by constricting blood vessels, which helps raise blood pressure and enhance blood flow to vital organs, thus supporting cardiovascular function during critical states. For example, in December 2023, the Australian Institute of Health and Welfare, a government agency in Australia, reported that doctor-certified deaths due to coronary heart disease (CHD) rose from 14,100 in 2021 to 14,900 in 2022. Consequently, the increasing rate of heart disease is contributing to the growth of the vasopressor market.
Leading players in the vasopressor market are concentrating on the development of advanced solutions such as intravenous (IV) vasopressors to better regulate blood pressure and improve patient outcomes. IV vasopressors are employed to constrict blood vessels and raise blood pressure in patients suffering from severe hypotension or shock, thereby ensuring sufficient blood flow to essential organs. For instance, in June 2023, Fresenius Kabi AG, a pharmaceutical company based in Germany, introduced Vasopressin Injection, USP, a generic version of Vasostrict, in the U.S. market, broadening its critical care product lineup. This drug is specifically indicated for adults experiencing vasodilatory shock who remain hypotensive after receiving fluids and catecholamines. It comes in a single-dose vial containing 20 units per 1 mL.
In April 2024, Endo Inc., a pharmaceutical company based in the United States, acquired assets from Endo International plc (EIP) for an undisclosed amount. Through this acquisition, Endo Inc. aims to enhance its financial stability, expand its product range, foster innovation, gain operational efficiencies, and strategically position itself for future growth in the pharmaceutical sector. Endo International plc, headquartered in Ireland, is a pharmaceutical firm known for manufacturing and distributing vasopressin.
Major players in the vasopressor market are Pfizer Inc., Merck And Co Inc., Novartis AG, Baxter International Inc., Fresenius Kabi AG, Bauch & Lomb Incorporated, Dr. Reddy's Laboratories Limited, Hikma Pharmaceuticals PLC, Endo Inc., Amphastar Pharmaceuticals Inc., American Regent Incorporated, Celon Laboratories Ltd., Athenex Inc., Sagent Pharmaceuticals Inc., Civica Rx, Eton Pharmaceuticals Inc., Amomed Pharma GmbH, Health Biotech Limited, Samarth Life Sciences Pvt. Ltd, and Pace Biotech Limited.
North America was the largest region in the vasopressor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in vasopressor report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the vasopressor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The vasopressor market consists of sales of norepinephrine, epinephrine, dopamine, and phenylephrine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Vasopressor Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on vasopressor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for vasopressor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vasopressor market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Catecholamines; Non-Catecholamines; Vasopressin
- 2) By Route Of Administration: Intravenous (IV); Intraosseous; Inhalational
- 3) By Applications: Hypotension Management; Septic Shock Treatment; Cardiogenic Shock Support; Post-Surgical Management; Other Critical Care Applications
- 4) By End Users: Hospitals; Ambulatory Surgical Centers; Emergency Medical Services; Home Care Settings
- Subsegments:-
- 1) By Catecholamines: Norepinephrine; Epinephrine; Dopamine; Isoproterenol
- 2) By Non-Catecholamines: Phenylephrine; Angiotensin II
- 3) By Vasopressin: Vasopressin
- Companies Mentioned: Pfizer Inc.; Merck And Co Inc.; Novartis AG; Baxter International Inc.; Fresenius Kabi AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Vasopressor Market Characteristics
3. Vasopressor Market Trends And Strategies
4. Vasopressor Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Vasopressor Growth Analysis And Strategic Analysis Framework
- 5.1. Global Vasopressor PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Vasopressor Market Growth Rate Analysis
- 5.4. Global Vasopressor Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Vasopressor Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Vasopressor Total Addressable Market (TAM)
6. Vasopressor Market Segmentation
- 6.1. Global Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Catecholamines
- Non-Catecholamines
- Vasopressin
- 6.2. Global Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Intravenous (IV)
- Intraosseous
- Inhalational
- 6.3. Global Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hypotension Management
- Septic Shock Treatment
- Cardiogenic Shock Support
- Post-Surgical Management
- Other Critical Care Applications
- 6.4. Global Vasopressor Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Ambulatory Surgical Centers
- Emergency Medical Services
- Home Care Settings
- 6.5. Global Vasopressor Market, Sub-Segmentation Of Catecholamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Norepinephrine
- Epinephrine
- Dopamine
- Isoproterenol
- 6.6. Global Vasopressor Market, Sub-Segmentation Of Non-Catecholamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Phenylephrine
- Angiotensin II
- 6.7. Global Vasopressor Market, Sub-Segmentation Of Vasopressin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Vasopressin (Desmopressin)
7. Vasopressor Market Regional And Country Analysis
- 7.1. Global Vasopressor Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Vasopressor Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Vasopressor Market
- 8.1. Asia-Pacific Vasopressor Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Vasopressor Market
- 9.1. China Vasopressor Market Overview
- 9.2. China Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Vasopressor Market
- 10.1. India Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Vasopressor Market
- 11.1. Japan Vasopressor Market Overview
- 11.2. Japan Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Vasopressor Market
- 12.1. Australia Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Vasopressor Market
- 13.1. Indonesia Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Vasopressor Market
- 14.1. South Korea Vasopressor Market Overview
- 14.2. South Korea Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Vasopressor Market
- 15.1. Western Europe Vasopressor Market Overview
- 15.2. Western Europe Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Vasopressor Market
- 16.1. UK Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Vasopressor Market
- 17.1. Germany Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Vasopressor Market
- 18.1. France Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Vasopressor Market
- 19.1. Italy Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Vasopressor Market
- 20.1. Spain Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Vasopressor Market
- 21.1. Eastern Europe Vasopressor Market Overview
- 21.2. Eastern Europe Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Vasopressor Market
- 22.1. Russia Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Vasopressor Market
- 23.1. North America Vasopressor Market Overview
- 23.2. North America Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Vasopressor Market
- 24.1. USA Vasopressor Market Overview
- 24.2. USA Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Vasopressor Market
- 25.1. Canada Vasopressor Market Overview
- 25.2. Canada Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Vasopressor Market
- 26.1. South America Vasopressor Market Overview
- 26.2. South America Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Vasopressor Market
- 27.1. Brazil Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Vasopressor Market
- 28.1. Middle East Vasopressor Market Overview
- 28.2. Middle East Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Vasopressor Market
- 29.1. Africa Vasopressor Market Overview
- 29.2. Africa Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Vasopressor Market Competitive Landscape And Company Profiles
- 30.1. Vasopressor Market Competitive Landscape
- 30.2. Vasopressor Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck And Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
31. Vasopressor Market Other Major And Innovative Companies
- 31.1. Bauch & Lomb Incorporated
- 31.2. Dr. Reddy's Laboratories Limited
- 31.3. Hikma Pharmaceuticals PLC
- 31.4. Endo Inc.
- 31.5. Amphastar Pharmaceuticals Inc.
- 31.6. American Regent Incorporated
- 31.7. Celon Laboratories Ltd.
- 31.8. Athenex Inc.
- 31.9. Sagent Pharmaceuticals Inc.
- 31.10. Civica Rx
- 31.11. Eton Pharmaceuticals Inc.
- 31.12. Amomed Pharma GmbH
- 31.13. Health Biotech Limited
- 31.14. Samarth Life Sciences Pvt. Ltd
- 31.15. Pace Biotech Limited
32. Global Vasopressor Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Vasopressor Market
34. Recent Developments In The Vasopressor Market
35. Vasopressor Market High Potential Countries, Segments and Strategies
- 35.1 Vasopressor Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Vasopressor Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Vasopressor Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
- 250617_r35014_Vasopressor_GMR_2025
